End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8,370 KRW | -1.99% | -5.21% | -53.83% |
Business Summary
Sales per Business
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Non-clinical
52.1
%
| 15,147 | 34.4 % | 13,848 | 52.1 % | -8.58% |
Analysis
24.3
%
| 8,006 | 18.2 % | 6,467 | 24.3 % | -19.22% |
Clinical
13.6
%
| 18,327 | 41.6 % | 3,617 | 13.6 % | -80.26% |
Efficacy
10.0
%
| 2,528 | 5.7 % | 2,654 | 10.0 % | +5.02% |
Sales per region
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
South Korea
99.6
%
| 43,948 | 99.9 % | 26,474 | 99.6 % | -39.76% |
Overseas
0.4
%
| 60 | 0.1 % | 112 | 0.4 % | +88.26% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chae-Kyu Park
CEO | Chief Executive Officer | 63 | 01/18/01 |
Su-Young Choi
PSD | President | 67 | 01/21/01 |
Hak-Jae Lee
BRD | Director/Board Member | 54 | 01/17/01 |
Deok-Sung Sun
BRD | Director/Board Member | 55 | 01/18/01 |
Jong-Myeong Song
AUD | Comptroller/Controller/Auditor | 50 | 01/22/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chae-Kyu Park
CEO | Chief Executive Officer | 63 | 01/18/01 |
Deok-Sung Sun
BRD | Director/Board Member | 55 | 01/18/01 |
Hak-Jae Lee
BRD | Director/Board Member | 54 | 01/17/01 |
Sung-Kyu Lee
BRD | Director/Board Member | 51 | 01/22/01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 12,770,512 | 7,382,287 ( 57.81 %) | 0 | 57.81 % |
Company contact information
Sector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
-53.83% | 7.99Cr | |
-24.63% | 782.87Cr | |
+70.87% | 432.49Cr | |
+1.53% | 263Cr | |
-7.18% | 252.97Cr | |
-44.62% | 229.44Cr | |
-12.67% | 181.86Cr | |
-19.62% | 150.86Cr | |
+18.85% | 121.86Cr | |
-43.60% | 116.64Cr |
- Stock Market
- Equities
- A383930 Stock
- Company DT&CRO CO., Ltd.